Madrigal Pharmaceuticals Aktie
488,60
EUR
+17,70
EUR
+3,76
%
554,69
USD
-4,30
USD
-0,77
%
Werbung
Madrigal Pharmaceuticals Aktie Analyse
| 10.06.19 | Madrigal Pharmaceuticals Buy | B. Riley FBR | |
| 28.02.19 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 14.12.18 | Madrigal Pharmaceuticals Outperform | Wolfe Research | |
| 12.12.18 | Madrigal Pharmaceuticals Neutral | B. Riley FBR | |
| 01.06.18 | Madrigal Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
| 01.06.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 30.01.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 06.12.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
| 29.11.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
Werbung
Werbung